Hypogonadisms
Also known as: Hypogonadism / Hypogonadism (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00286 | Conjugated estrogens | A mixture of estrogens used in estrogen replacement therapy for menopause and hypoestrogenism, used in the treatment of various malignancies, and used in the treatment of postmenopausal osteoporosis. |
DB09381 | Esterified estrogens | A female hormone used to treat conditions related to estrogen deficiency and moderate to severe vasomotor menopausal symptoms in women. |
DB00783 | Estradiol | An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate. |
DB13954 | Estradiol cypionate | An estradiol prodrug used to treat vasomotor symptoms and hypoestrogenisms from hypogonadism. |
DB13956 | Estradiol valerate | An estradiol prodrug used to treat some effects of menopause, hypoestrogenism, androgen dependant carcinoma of the prostate, and in combination products for endometriosis and contraception. |
DB04574 | Estrone sulfate | An estrogen used as monotherapy or in several combination hormone replacement products for managing menopause symptoms and hormone disorders. |
DB13587 | Mesterolone | An anabolic steroid indicated in the treatment of low testosterone, hypogonadism, oligozoospermia, and Leydig cell failure. |
DB00717 | Norethisterone | A synthetic second-generation progestin used for contraception, prevention of endometrial hyperplasia in hormone replacement therapy, and in the treatment of other hormone-mediated illnesses such as endometriosis. |
DB06285 | Teriparatide | A recombinant parathyroid hormone used for the treatment of osteoporosis. |